- Home
- PFE vs BUD Comparison
PFE vs BUD Comparison
Compare PFE & BUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFE
- BUD
- Stock Information
- Founded
- PFE 1849
- BUD 1366
- Country
- PFE United States
- BUD Belgium
- Employees
- PFE N/A
- BUD N/A
- Industry
- PFE Biotechnology: Pharmaceutical Preparations
- BUD Beverages (Production/Distribution)
- Sector
- PFE Health Care
- BUD Consumer Staples
- Exchange
- PFE Nasdaq
- BUD Nasdaq
- Market Cap
- PFE 140.8B
- BUD 115.1B
- IPO Year
- PFE N/A
- BUD N/A
- Fundamental
- Price
- PFE $24.65
- BUD $60.90
- Analyst Decision
- PFE Hold
- BUD Buy
- Analyst Count
- PFE 11
- BUD 2
- Target Price
- PFE $29.20
- BUD $71.50
- AVG Volume (30 Days)
- PFE 55.9M
- BUD 2.1M
- Earning Date
- PFE 11-04-2025
- BUD 10-30-2025
- Dividend Yield
- PFE 6.98%
- BUD 1.39%
- EPS Growth
- PFE N/A
- BUD N/A
- EPS
- PFE 1.89
- BUD 3.12
- Revenue
- PFE $63,833,000,000.00
- BUD $58,605,000,000.00
- Revenue This Year
- PFE $0.04
- BUD $1.09
- Revenue Next Year
- PFE N/A
- BUD $5.48
- P/E Ratio
- PFE $13.04
- BUD $19.54
- Revenue Growth
- PFE 13.53
- BUD N/A
- 52 Week Low
- PFE $20.92
- BUD $45.94
- 52 Week High
- PFE $28.64
- BUD $72.13
- Technical
- Relative Strength Index (RSI)
- PFE 48.44
- BUD 50.55
- Support Level
- PFE $24.15
- BUD $59.64
- Resistance Level
- PFE $24.83
- BUD $62.17
- Average True Range (ATR)
- PFE 0.35
- BUD 0.83
- MACD
- PFE -0.05
- BUD -0.01
- Stochastic Oscillator
- PFE 61.73
- BUD 50.80
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
About BUD Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
Anheuser-Busch InBev is the largest brewer in the world and one of the world's top five consumer product companies, as measured by EBITDA. The company's portfolio contains six of the top 10 beer brands by volume, according to Euromonitor, and we estimate it distributes 23 brands with retail sales over $1 billion. AB InBev was created by the 2008 merger of Belgium-based InBev and US-based Anheuser-Busch. The firm holds a 62% economic interest in Ambev, an 87% stake in Budweiser APAC, and in 2016 it acquired SABMiller.